OFA
ABBV icon

Oak Family Advisors’s AbbVie ABBV Stock Holding History

Oak Family Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Sell
10,503
-559
-5% -$120K 0.68% 41
2026
Q1 		$2.41M Sell
11,062
-29
-0.3% -$6.43K 0.68% 45
2025
Q4 		$2.53M Sell
11,091
-14
-0.1% -$3.19K 0.7% 44
2025
Q3 		$2.57M Sell
11,105
-98
-0.9% -$20K 0.64% 45
2025
Q2 		$2.08M Sell
11,203
-1,103
-9% -$205K 0.66% 41
2025
Q1 		$2.58M Sell
12,306
-493
-4% -$95.8K 0.87% 36
2024
Q4 		$2.27M Sell
12,799
-138
-1% -$25.4K 0.82% 38
2024
Q3 		$2.55M Sell
12,937
-168
-1% -$31.4K 0.79% 36
2024
Q2 		$2.25M Sell
13,105
-326
-2% -$54K 0.77% 36
2024
Q1 		$2.45M Sell
13,431
-278
-2% -$47.9K 0.94% 35
2023
Q4 		$2.12M Sell
13,709
-378
-3% -$55.1K 0.89% 37
2023
Q3 		$2.1M Sell
14,087
-262
-2% -$38.5K 0.99% 36
2023
Q2 		$1.93M Sell
14,349
-406
-3% -$59.5K 0.92% 35
2023
Q1 		$2.35M Sell
14,755
-2,441
-14% -$373K 1.16% 30
2022
Q4 		$2.78M Sell
17,196
-4,425
-20% -$678K 1.49% 26
2022
Q3 		$2.9M Sell
21,621
-5,096
-19% -$731K 1.55% 20
2022
Q2 		$4.09M Sell
26,717
-8,295
-24% -$1.27M 2.06% 11
2022
Q1 		$5.68M Sell
35,012
-15,739
-31% -$2.29M 2.22% 7
2021
Q4 		$6.87M Sell
50,751
-7,695
-13% -$909K 2.57% 5
2021
Q3 		$6.3M Buy
58,446
+1,606
+3% +$184K 2.3% 4
2021
Q2 		$6.4M Buy
56,840
+1,340
+2% +$151K 2.67% 5
2021
Q1 		$6.01M Buy
55,500
+3,920
+8% +$419K 2.61% 5
2020
Q4 		$5.53M Buy
+51,580
New +$4.96M 2.86% 5

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Oak Family Advisors's ABBV Position: Q2 2026 in Review

Oak Family Advisors reduced its AbbVie (ABBV) stake by 5.1% in Q2 2026, selling an estimated $120K and leaving 10,503 shares worth $2.64M. The position accounts for 0.68% of the portfolio, ranked #41.

Oak Family Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.87M in Q4 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Oak Family Advisors held 10,503 shares of AbbVie worth $2.64M as of Q2 2026.
  • Oak Family Advisors sold 559 AbbVie shares in Q2 2026, an estimated $120K.
  • AbbVie made up 0.68% of Oak Family Advisors's portfolio in Q2 2026, its #41 holding.
  • Oak Family Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Oak Family Advisors's AbbVie position peaked at $6.87M in Q4 2021.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Oak Family Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.